Brief: Astrazeneca Pharma India Sept-Quarter PAT 384.3 Mln Rupees
13/11/2024 11:23
Nov 13 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* SEPT-QUARTER PAT 384.3 MILLION RUPEES
* SEPT-QUARTER REVENUE FROM OPERATIONS 4.08 BILLION RUPEES
Source text: ID:
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication